Ultragenyx Pharmaceutical | RARE - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 -1.04 -1.81 Nov/04
FY2026Q2 Jun/2026 -1.23 -1.17 Jul/30
FY2026Q1 Mar/2026 -1.84 -1.43 -1.57 May/05
FY2025Q4 Dec/2025 -1.29 -1.17 -1.39 Feb/12
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04




Eps Alterar Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Immunic USD -0.1 0.03 2025-12
Insmed USD -0.76 0.78 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Kyowa Hakko Kirin JPY 22.99 42.8 2026-03
MacroGenics USD -0.58 0.36 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03